Jeffrey Strovel

Regulation of Apoptosis by a Prostate-Specific and Prostate Cancer-Associated Noncoding Gene, PCGEM1

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

Cancer stem cells revisited

Telomeres and telomerase: A dual role in hepatocarcinogenesis

Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy

The hallmarks of cancer

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways

Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells

Long Noncoding RNA and Cancer: A New Paradigm

Combination therapy in combating cancer

Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug

Characterization of Frequently Deleted 6q Locus in Prostate Cancer

Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65 – a novel Wnt/β-catenin signaling inhibitor

A Novel β-catenin Inhibitor, AV65 Suppresses the Growth of CML Cell Lines Which Acquire Imatinib-Resistance Because of Abl Kinase Domain Mutations Including T315I and Hypoxia-Adaptation.

AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model

Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection.